LabWare wishes to reassure you that we are well-positioned to support you during the COVID-19 emergency. LabWare is ready and able to deliver service and support effectively via remote means, and our team is already operating from their home bases. We are a software and service supplier, and not dependent on shipment of physical materials or a need to visit your site for continuous periods.
We also wish to assure you that LabWare is financially strong, and we are confident our international team can maintain near-normal business operations over the coming months.
Since mid-February LabWare has been actively working with public and private sector organizations around the world to apply our considerable know-how and advanced technology to implement COVID-19 testing capability as well as other workflow and operational efficiency enhancements to increase laboratory testing capacity to meet unprecedented public health testing demands.
Our efforts include assisting in the efforts to expand the NHS COVID-19 testing operations in the U.K.; providing laboratory management software for a new COVID-19 laboratory in Sao Paulo, Brazil; assisting U.S. public health customers implement new COVID-19 tests and communications protocols for reporting to the CDC; and adding/expanding COVID-19 testing capabilities throughout our public health customer base in sub Saharan Africa.
We are also developing solutions that leverage LabWare's mobile technology to streamline the COVID-19 patient registration and sample collection process as part of field-based specimen collection and COVID-19 testing operations. These solutions are being piloted with our state public health lab customers.
If you need any additional service to help maintain business operations during this challenging time, please do not hesitate to contact LabWare, and we will do our best to assist.